New biological and translational insights in CLL

 Chronic lymphoid malignancies
 Biology
 Translational
 Lymphoid malignancies and plasma cell disorders

On-demand
English
Oral Session
11 June 2021 9:00 AM - 9:00 AM


Presentations

Title Time Appointment
p408-1 (S140) CANCER STEMNESS ASSOCIATES WITH HIGH EXPRESSION LEVEL OF ROR1 AND VENETOCLAX RESISTANCE IN CHRONIC LYMPHOCYTIC LEUKEMIA
11 June 2021 9:00 AM - 9:00 AM
p408-2 (S141) SKEWED PRIMARY ANTIGEN-SPECIFIC RESPONSES AND CHROMATIN REMODELING OF T CELLS IN A COMBINED OT-I/TCL-1 ADOPTIVE TRANSFER MODEL
11 June 2021 9:00 AM - 9:00 AM
p408-3 (S142) FOXO1-GAB1 AXIS REGULATES HOMING CAPACITY AND TONIC AKT ACTIVITY IN CHRONIC LYMPHOCYTIC LEUKEMIA: NOVEL THERAPEUTIC TARGET
11 June 2021 9:00 AM - 9:00 AM
p408-4 (S143) CLINICAL IMPACT OF RECURRENT GENE MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA: A RETROSPECTIVE, MULTI-CENTER COHORT STUDY BY ERIC, THE EUROPEAN RESEARCH INITIATIVE ON CLL, IN HARMONY
11 June 2021 9:00 AM - 9:00 AM
p408-5 (S144) GENETIC MARKERS AND OUTCOME IN FRONT LINE OBINUTUZUMAB PLUS CHLORAMBUCIL OR VENETOCLAX - UPDATED ANALYSIS OF THE CLL14 TRIAL
11 June 2021 9:00 AM - 9:00 AM